We invite you to experience the BUBS difference for yourself
While GHK-Cu is generally well-tolerated in topical research, certain contraindications or precautions should be considered, especially for systemic research or in specific populations: Systemic Research: For systemic applications, GHK-Cu is generally not recommended for subjects who are pregnant, breastfeeding, have active cancer, or suffer from Wilsons disease (a condition involving copper accumulation)
Invest in their defense, rebuild from within, and let true resilience start at the source, your cells
Results from Combined Metabolic Activators (CMA) trials CMA trials have shown remarkable results
Many online claims exaggerate early-stage findings into metabolic promises that researchers have not yet demonstrated in humans
Consulting a doctor or medical professional is recommended prior to any procedure